Matthew Clement

577 total citations
5 papers, 467 citations indexed

About

Matthew Clement is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Matthew Clement has authored 5 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Genetics, 2 papers in Pathology and Forensic Medicine and 2 papers in Oncology. Recurrent topics in Matthew Clement's work include Acute Lymphoblastic Leukemia research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Matthew Clement is often cited by papers focused on Acute Lymphoblastic Leukemia research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Matthew Clement collaborates with scholars based in United States, United Kingdom and Germany. Matthew Clement's co-authors include Andrew K. Sewell, Linda Wooldridge, Emma Gostick, David A. Price, Ruth Seggewiss, Vishal S. Vaidya, Joseph V. Bonventre, Angharad E. Fenton-May, Dana Hoffmann and Angela Mally and has published in prestigious journals such as Blood, Clinical Cancer Research and Toxicological Sciences.

In The Last Decade

Matthew Clement

5 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Clement United States 5 193 155 144 94 83 5 467
Célia Salanoubat France 9 275 1.4× 141 0.9× 280 1.9× 51 0.5× 289 3.5× 13 634
Paula Fernández‐Calotti Argentina 11 146 0.8× 145 0.9× 47 0.3× 65 0.7× 29 0.3× 17 396
Yoichiro Ogama Japan 10 116 0.6× 190 1.2× 34 0.2× 110 1.2× 72 0.9× 16 609
Yi‐Hua Chen United States 11 51 0.3× 128 0.8× 88 0.6× 63 0.7× 33 0.4× 35 384
Hillard Lazarus United States 11 61 0.3× 220 1.4× 65 0.5× 163 1.7× 345 4.2× 17 699
Kendall W Cradic United States 11 50 0.3× 203 1.3× 34 0.2× 83 0.9× 34 0.4× 19 492
Luc‐Matthieu Fornecker France 13 102 0.5× 109 0.7× 263 1.8× 83 0.9× 84 1.0× 37 537
Laurie Iciek United States 5 70 0.4× 218 1.4× 57 0.4× 78 0.8× 129 1.6× 7 407
Mei Yan United States 14 446 2.3× 178 1.1× 38 0.3× 100 1.1× 28 0.3× 18 729
Jie Bai China 15 111 0.6× 336 2.2× 161 1.1× 50 0.5× 252 3.0× 76 635

Countries citing papers authored by Matthew Clement

Since Specialization
Citations

This map shows the geographic impact of Matthew Clement's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Clement with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Clement more than expected).

Fields of papers citing papers by Matthew Clement

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Clement. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Clement. The network helps show where Matthew Clement may publish in the future.

Co-authorship network of co-authors of Matthew Clement

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Clement. A scholar is included among the top collaborators of Matthew Clement based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Clement. Matthew Clement is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Krishnamoorthy, Aparna, Matthew Clement, Eileen O’Leary, Joseph V. Bonventre, & Vishal S. Vaidya. (2010). TIM2 Gene Deletion Results in Susceptibility to Cisplatin-Induced Kidney Toxicity. Toxicological Sciences. 118(1). 298–306. 6 indexed citations
2.
Hoffmann, Dana, Melanie Adler, Vishal S. Vaidya, et al.. (2009). Comparative Analysis of Novel Noninvasive Renal Biomarkers and Metabonomic Changes in a Rat Model of Gentamicin Nephrotoxicity. Toxicological Sciences. 109(2). 336–349. 108 indexed citations
3.
Wooldridge, Linda, Matthew Clement, Angharad E. Fenton-May, et al.. (2008). Profound Inhibition of Antigen-Specific T-Cell Effector Functions by Dasatinib. Clinical Cancer Research. 14(8). 2484–2491. 106 indexed citations
4.
Lissina, Anna, Kristin Ladell, Ania Skowera, et al.. (2008). Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers. Journal of Immunological Methods. 340(1). 11–24. 117 indexed citations
5.
Hewamana, Saman, Thet Thet Lin, Matthew Clement, et al.. (2008). The NF-κB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target. Blood. 111(9). 4681–4689. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026